CLIC function in GPCR-mediated Rho/Rac signaling

CLIC 在 GPCR 介导的 Rho/Rac 信号传导中的功能

基本信息

  • 批准号:
    9973544
  • 负责人:
  • 金额:
    $ 42.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

G-protein-coupled receptor (GPCR)-mediated regulation of the GTPases Rho and Rac is a conserved signaling module required for vital cell behaviors. However, the mechanisms that connect GPCRs, and their heterotrimeric G-protein (Gα/β/γ) partners, to Rho/Rac are not fully delineated. Our studies in C. elegans and human endothelial cells have revealed a new conserved player required for Rho/Rac signaling: the Chloride Intracellular Channel (CLIC) family of proteins. Our data shows that CLICs are required in two important endothelial GPCR pathways (S1P/S1P Receptor and thrombin/PAR) that function through Gα12/13 and Gαi to activate Rho and Rac. This CLIC function is evolutionarily conserved, because we found that in C. elegans the CLIC ortholog exc-4 genetically interacts with the Gα12 ortholog gpa-12 and with the Rac orthologs ced-10 and mig-2. The molecular function of CLICs has long remained a mystery. Based on sequence and structural similarities, they have been proposed to function as chloride channels and/or as glutathione S-transferases (GST). Previous work has shown that EXC-4 membrane localization is mediated by an N-terminal domain and this localization is critical for function. We have now found that CLIC membrane localization is also critical for its role in GPCR-mediated Rho/Rac activation in endothelial cells, and that replacement of the membrane-targeting N-terminus with a myristoylation signal is sufficient to restore this function. Since the channel and GST activities of CLICs require an intact N- terminus we have discovered a novel activity for CLICs. We hypothesize that CLICs are membrane-localized regulators of Rho and Rac that respond to GPCR-Gα signaling. In Aim 1 we will determine how CLICs couple GPCR-Gα (Gα12/13 and Gαi) signaling to Rho and Rac. We will survey the requirement for CLICs in different cell and signaling contexts to define key GPCR-Gα combinations that utilize CLICs to regulate of Rho and Rac. We will use cutting-edge bio-sensors and genetic tools to measure and modulate signaling to determine which step in the GPCR-Gαβγ-Rho/Rac cascade requires CLICs. Finally, we will test whether CLICs physically interact with Rho/Rac to modulate signaling. In Aim 2 we will define the determinants by which CLICs regulate Rho/Rac in human cells and in C. elegans by performing structure-function analyses, focused on the EXC-4/CLIC C- terminus. Critical domains defined in this Aim will be tested for their ability to interact with Rho/Rac (as defined in Aim 1). In Aim 3 we will carry out unbiased genetic and proteomic screens in C. elegans to find conserved players that genetically and physically interact with EXC-4/CLIC to further elucidate how CLICs regulate Rho/Rac signaling. We will then test whether human orthologs of genes identified in these screens influence Rho/Rac signaling in mammalian cells. By defining new mechanisms of action for CLICs in GPCR-Gαβγ-Rho/Rac signaling we will significantly increase our knowledge of how GPCRs influence human biology and uncover new ways of targeting these pathways.
G蛋白偶联受体(GPCR)介导的GTP酶Rho和Rac的调节是一种保守的信号传导途径, 重要细胞行为所需的模块。然而,连接GPCR及其异源三聚体的机制, G-蛋白(Gα/β/γ)伴侣与Rho/Rac的关系尚未完全阐明。我们在C.秀丽线虫和人类内皮细胞 细胞揭示了Rho/Rac信号传导所需的一个新的保守参与者:细胞内氯离子通道 (CLIC)蛋白质家族。我们的数据显示CLIC在两个重要的内皮GPCR途径中是必需的 (S1P/S1 P受体和凝血酶/PAR),其通过Gα12/13和Gαi起作用以激活Rho和Rac。这 CLIC功能在进化上是保守的,因为我们发现在C. elegans的CLIC直系同源物exc-4 与Gα12直系同源物gpa-12以及与Rac直系同源物ced-10和mig-2遗传相互作用。分子 CLIC的功能长期以来一直是一个谜。基于序列和结构的相似性, 提出作为氯离子通道和/或谷胱甘肽S-转移酶(GST)起作用。以前的工作表明 EXC-4膜定位是由N-末端结构域介导的,并且这种定位对于功能至关重要。 我们现在发现CLIC膜定位对于其在GPCR介导的Rho/Rac中的作用也是关键的 在内皮细胞中的活化,以及用豆蔻酰化取代膜靶向N-末端 信号足以恢复该功能。由于CLIC的通道和GST活动需要完整的N- 我们发现了CLIC的一种新活性。我们假设CLIC是膜定位的, 响应GPCR-Gα信号传导的Rho和Rac调节子。在目标1中,我们将确定CLIC如何耦合 GPCR-Gα(Gα12/13和Gαi)向Rho和Rac的信号传导。我们将调查不同单元对CLIC的需求 和信号传导上下文来定义利用CLIC来调节Rho和Rac的关键GPCR-Gα组合。我们 将使用尖端的生物传感器和遗传工具来测量和调节信号,以确定哪一步 在GPCR-Gαβγ-Rho/Rac级联中,需要CLIC。最后,我们将测试CLIC是否与 Rho/Rac调节信号传导。在目标2中,我们将定义CLIC调节Rho/Rac的决定因素, 人细胞和C. elegans的结构-功能分析,重点是EXC-4/CLIC C- 终点站将测试本目标中定义的关键域与Rho/Rac(如定义)相互作用的能力 目标1)。在目标3中,我们将在C. elegans发现保守的 基因和物理上与EXC-4/CLIC相互作用的参与者,以进一步阐明CLIC如何调节Rho/Rac 发信号。然后,我们将测试在这些筛选中鉴定的基因的人类直系同源物是否影响Rho/Rac 哺乳动物细胞中的信号传导。通过定义CLIC在GPCR-Gαβγ-Rho/Rac信号传导中的新作用机制, 我们将大大增加我们对GPCR如何影响人类生物学的了解,并发现新的方法, 针对这些路径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jan K. Kitajewski其他文献

Correction to: Notch regulates vascular collagen IV basement membrane through modulation of lysyl hydroxylase 3 trafficking
  • DOI:
    10.1007/s10456-021-09801-w
  • 发表时间:
    2021-06-08
  • 期刊:
  • 影响因子:
    9.200
  • 作者:
    Stephen J. Gross;Amelia M. Webb;Alek D. Peterlin;Jessica R. Durrant;Rachel J. Judson;Qanber Raza;Jan K. Kitajewski;Erich J. Kushner
  • 通讯作者:
    Erich J. Kushner

Jan K. Kitajewski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jan K. Kitajewski', 18)}}的其他基金

CLIC function in GPCR-mediated Rho/Rac signaling
CLIC 在 GPCR 介导的 Rho/Rac 信号传导中的功能
  • 批准号:
    10552564
  • 财政年份:
    2020
  • 资助金额:
    $ 42.63万
  • 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
  • 批准号:
    10427309
  • 财政年份:
    2019
  • 资助金额:
    $ 42.63万
  • 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
  • 批准号:
    10646394
  • 财政年份:
    2019
  • 资助金额:
    $ 42.63万
  • 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
  • 批准号:
    9902520
  • 财政年份:
    2019
  • 资助金额:
    $ 42.63万
  • 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
  • 批准号:
    9793609
  • 财政年份:
    2019
  • 资助金额:
    $ 42.63万
  • 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
  • 批准号:
    10186473
  • 财政年份:
    2019
  • 资助金额:
    $ 42.63万
  • 项目类别:
CLIC function in angiogenesis
CLIC 在血管生成中的功能
  • 批准号:
    8653256
  • 财政年份:
    2013
  • 资助金额:
    $ 42.63万
  • 项目类别:
CLIC function in angiogenesis
CLIC 在血管生成中的功能
  • 批准号:
    9295237
  • 财政年份:
    2013
  • 资助金额:
    $ 42.63万
  • 项目类别:
CLIC function in angiogenesis
CLIC 在血管生成中的功能
  • 批准号:
    9181450
  • 财政年份:
    2013
  • 资助金额:
    $ 42.63万
  • 项目类别:
CLIC function in angiogenesis
CLIC 在血管生成中的功能
  • 批准号:
    8787785
  • 财政年份:
    2013
  • 资助金额:
    $ 42.63万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 42.63万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 42.63万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 42.63万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 42.63万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 42.63万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 42.63万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 42.63万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 42.63万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 42.63万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 42.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了